BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
110 hedge funds and large institutions have $287M invested in BioDelivery Sciences International, Inc. in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 31 increasing their positions, 38 reducing their positions, and 21 closing their positions.
674% more call options, than puts
Call options by funds: $851K | Put options by funds: $110K
38% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 21
7% more funds holding
Funds holding: 103 → 110 (+7)
5% more capital invested
Capital invested by funds: $273M → $287M (+$14.1M)
18% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 38
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$18.8M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$8.61M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$7.13M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.75M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$5.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$8.04M |
| 2 |
Millennium Management
New York
|
-$6.18M |
| 3 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$3.8M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$3.04M |
| 5 |
Goldman Sachs
New York
|
-$2.96M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EMG
126
Ellington Management Group
Old Greenwich,
Connecticut
| – | -$66K | -12,500 | Closed |
|
127
Simplex Trading
Chicago,
Illinois
| – | -$54.9K | -11,786 | Closed |
|
|
QC
128
QCM Cayman
Houston,
Texas
| – | -$35K | -11,253 | Closed |
|
|
FAAS
129
First Allied Advisory Services
San Diego,
California
| – | -$58K | -10,951 | Closed |
|
130
Group One Trading
Chicago,
Illinois
| – | -$19.4K | -4,168 | Closed |
|
131
Walleye Capital
New York
| – | -$10.2K | -2,200 | Closed |
|
BDSI Hedge Fund Activity: Q2 2019 in Review
110 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2019, worth a combined $287M — up 5.2% from $273M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new BDSI positions and 21 closed out — a net gain of 8 holders — while 31 added to existing stakes and 38 trimmed.
The largest buyer was BlackRock, adding an estimated $18.8M. The largest seller was Morgan Stanley, cutting an estimated $8.04M.
- 110 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2019, up from 103 in Q1 2019.
- Funds reported $287M of BioDelivery Sciences International, Inc. stock for Q2 2019, up 5.2% quarter-over-quarter.
- 29 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2019 and 21 closed out, a net change of +8 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q2 2019 was BlackRock, an estimated $18.8M added.
- The largest BioDelivery Sciences International, Inc. seller in Q2 2019 was Morgan Stanley, an estimated $8.04M sold.
Based on aggregated 13F filings for Q2 2019.